乙酰胆碱酯酶
疾病
药理学
淀粉样前体蛋白
医学
中医药
阿切
不利影响
淀粉样前体蛋白分泌酶
阿尔茨海默病
酶
生物
生物化学
内科学
病理
替代医学
作者
Dai Renhui,Ying-ni Sun,Ruiling Su,Hongwei Gao
标识
DOI:10.1016/j.biopha.2022.113576
摘要
Alzheimer's disease (AD) is a common neurodegenerative disease that often occurs in the elderly population. At present, most drugs for AD on the market are single-target drugs, which have achieved certain success in the treatment of AD. However, the efficacy and safety of single-target drugs have not achieved the expected results because AD is a multifactorial disease. Multi-targeted drugs act on multiple factors of the disease network to improve efficacy and reduce adverse reactions. Therefore, the search for effective dual-target or even multi-target drugs has become a new research trend. Many of results found that the dual-target inhibitors of the beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) and acetylcholinesterase (AChE) found from traditional Chinese medicine have a good inhibitory effect on AD with fewer side effects. This article reviews sixty-six compounds extracted from Chinese medicinal herbs, which have inhibitory activity on BACE1 and AChE. This provides a theoretical basis for the further development of these compounds as dual-target inhibitors for the treatment of AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI